Genetic research
A new investigation from the Tianjin Medical University General Hospital in China has shed light on the potential of personalized medicine in the treatment of lung adenocarcinoma (LUAD). Researchers found that specific glycan-related genes can predict patient outcomes, suggesting that tailored treatments could be more effective. The study's
Biochemistry
A groundbreaking study published in the Journal of Dairy Science has employed single-nucleus RNA sequencing (snRNA-seq) to map the cellular landscape of the mammary gland in Mongolian horses across four physiological stages. The research, conducted by a team of scientists at Northwest A&F University, has provided high-resolution insights
Genetic research
New research has highlighted the potential of nucleic acid-based therapies (NATs) to treat currently undrugable or ultrarare diseases. Investigators from Integrated DNA Technologies have developed a comprehensive review of the most employed chemical modifications in NATs, which includes antisense oligonucleotides, RNA interference, splice-shifting oligonucleotides, messenger RNA, and CRISPR/Cas gene
Biochemistry
Current study results on Proteins - Nucleoproteins have been published, with a team of researchers at the University of Louisville making a significant discovery in understanding the RNA binding mechanisms of chromatin-binding proteins PARP1 and MeCP2. The study revealed that both proteins possess RNA-binding properties, but the mechanism by which
Genetic research
Researchers at Nanyang Technological University have made significant discoveries in the field of cancer gene therapy, providing new insights into the mechanisms of chemoresistance in multiple myeloma. According to a study published in Nature Communications, a long non-coding RNA termed PLUM is overexpressed in NF-κB mutant high-risk MM subtypes and
Biochemistry
Researchers at the University of Edinburgh have shed light on the intricate relationships between RNA and proteins in the cell nucleus, revealing a complex network of affinity that shapes chromatin architecture and transcription factor mobility. This research has significant implications for our understanding of genome organization and folding. The study
Biochemistry
Research conducted at Shandong First Medical University in China has shed light on the relationship between extrachromosomal circular DNA (eccDNA) and hepatocellular carcinoma (HCC). The study employed Circle-seq and RNA-seq on six pairs of HCC tumors and adjacent non-tumor tissues, identifying a 3 Mb extrachromosomal DNA (ecDNA) from chromosome 1q21
Biochemistry
Researchers at the Spanish National Centre for Biotechnology (CNB-CSIC) have made a groundbreaking discovery in the field of oncology by identifying extracellular vesicles (EVs) as the primary carriers of fusion RNA in non-small cell lung cancer (NSCLC) patients. This finding has significant implications for the diagnosis and treatment of NSCLC,
Genetic research
Researchers at the J. Craig Venter Institute have made significant advances in using machine learning to analyze large-scale single cell RNA sequencing data. The breakthrough utilizes the NS-Forest algorithm, a random forest-based approach that identifies minimally sufficient marker genes for cell type classification with high accuracy. This development holds promise
Genetic research
Researchers from the Yunnan Academy of Agricultural Sciences conducted a comprehensive study to understand the transcriptional profile of peony seeds across diverse altitudes and developmental stages. The study, published in the journal Genes, used Pacbio full-length cDNA sequencing to identify 39,267 full-length transcripts, with 80.03% achieving successful annotation.
Neurophysiology
Secarna Pharmaceuticals and Vect-Horus have formed a research collaboration to develop RNA-targeted therapeutics for central nervous system (CNS) disorders, combining Secarna's OligoCreator technology with Vect-Horus' VECTrans platform. The partnership aims to enable systemic delivery of oligonucleotide therapies across the blood-brain barrier, expanding the presence of both companies
